This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Japan as Represented by the Director-General of National Institute of Infections Diseases, Osaka University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Asato Kojima: Innovator in Virus-Like Particle Technology
Introduction
Asato Kojima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of virology, particularly in the development of virus-like particles (VLPs). His innovative work has implications for vaccine development and infectious disease research.
Latest Patents
Kojima holds a patent for a groundbreaking invention titled "West Nile virus prM-E signal peptide facilitating the efficient assembly, maturation, and release of virus-like particles (VLPs)." This invention provides a method for producing highly secreting virus-like particles derived from the West Nile virus. The patent includes a WNV VLP secretion expression vector, an animal cell line for VLP production, and potential applications in WNV vaccines.
Career Highlights
Throughout his career, Asato Kojima has worked with esteemed institutions such as the National Institute of Infectious Diseases and Osaka University. His research has focused on enhancing the efficiency of VLP production, which is crucial for developing effective vaccines against viral infections.
Collaborations
Kojima has collaborated with notable colleagues, including Hidehiro Takahashi and Toyokazu Ishikawa. These partnerships have contributed to advancing research in the field of infectious diseases and vaccine development.
Conclusion
Asato Kojima's innovative work in the field of virology, particularly with virus-like particles, showcases his dedication to advancing medical science. His contributions have the potential to significantly impact vaccine development and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile